Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
613.67B
Market cap613.67B
Price-Earnings ratio
29.32
Price-Earnings ratio29.32
Dividend yield
2.09%
Dividend yield2.09%
Average volume
7.12M
Average volume7.12M
High today
$254.78
High today$254.78
Low today
$251.17
Low today$251.17
Open price
$253.50
Open price$253.50
Volume
2.19M
Volume2.19M
52 Week high
$281.07
52 Week high$281.07
52 Week low
$182.94
52 Week low$182.94

Stock Snapshot

With a market cap of 613.67B, Johnson & Johnson(JNJ) trades at $254.65. The stock has a price-to-earnings ratio of 29.32 and currently yields dividends of 2.09%.

As of 2026-10-06, Johnson & Johnson(JNJ) stock has fluctuated between $251.17 and $254.78. The current price stands at $254.65, placing the stock +1.4% above today's low and -0.1% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 2.19M, compared to an average daily volume of 7.12M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $182.94.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $182.94.

JNJ News

TipRanks 4h
Johnson & Johnson price target raised to $290 from $287 at RBC Capital

RBC Capital analyst Trung Huynh raised the firm’s price target on Johnson & Johnson to $290 from $287 and keeps an Outperform rating on the shares. The firm not...

24/7 Wall St. 5h
Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It

Investing Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It Both Dividend Kings trade at nearly identical valu...

Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It
Axios 7h
Longevity guru Bryan Johnson: "People really want me to die" - Axios

...

Longevity guru Bryan Johnson: "People really want me to die" - Axios

Analyst ratings

70%

of 27 ratings
Buy
70.4%
Hold
22.2%
Sell
7.4%

More JNJ News

The Motley Fool 1d
Looking for a Dividend Stock That Can Weather a Downturn? Start With Johnson & Johnson.

When considering defensive dividend stocks, the healthcare sector is a great place to look. After all, even during a recession, people need medicine and surgery...

Looking for a Dividend Stock That Can Weather a Downturn? Start With Johnson & Johnson.
24/7 Wall St. 2d
Municipal Bonds vs Dividend Stocks: Which Income Actually Keeps More of Your Money?

Investing Municipal Bonds vs Dividend Stocks: Which Income Actually Keeps More of Your Money? Your tax bracket quietly decides whether muni bonds or dividend st...

Municipal Bonds vs Dividend Stocks: Which Income Actually Keeps More of Your Money?
The Motley Fool 3d
Wall Street Is Bracing for the Fed's Next Move on Rates. These 3 Stocks Win Either Way.

Bond yields are rising, inflation remains above the Federal Reserve's target, and there has already been one Fed rate hike. Wall Street is bracing for further r...

Wall Street Is Bracing for the Fed's Next Move on Rates. These 3 Stocks Win Either Way.
24/7 Wall St. 4d
Dave Ramsey Says Single Stocks Are a Gamble. What That Means if You Live on Dividends

Investing Dave Ramsey Says Single Stocks Are a Gamble. What That Means if You Live on Dividends Dave Ramsey has called single stocks a gamble for years, but ret...

Dave Ramsey Says Single Stocks Are a Gamble. What That Means if You Live on Dividends
Simply Wall St 4d
What Is Johnson & Johnson Signaling With Gene Therapy And AI Repurposing?

Johnson & Johnson (NYSE: JNJ) advanced its gene therapy candidate Botaretigene sparoparvovec for X-linked retinitis pigmentosa in ongoing regulatory and clinica...

What Is Johnson & Johnson Signaling With Gene Therapy And AI Repurposing?
TipRanks 4d
Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

Johnson & Johnson announced new two-year data from the Phase 3 ICONIC-TOTAL study demonstrating the positive impact of ICOTYDE on high-impact plaque psoriasis s...

The Motley Fool 5d
Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?

Choosing between the diversified stability of Johnson & Johnson (JNJ -2.30%) and the rapid growth trajectory of Eli Lilly & Co (LLY -0.63%) is a primary conside...

Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.